Leptospiral LPS escapes mouse TLR4 internalization and TRIF‑associated antimicrobial responses through O antigen and associated lipoproteins-Reference-Cited by-同舟云学术

Leptospiral LPS escapes mouse TLR4 internalization and TRIF‑associated antimicrobial responses through O antigen and associated lipoproteins

Published:2020-08-13 Issue:8 Volume:16 Page:e1008639
ISSN:1553-7374
Container-title:PLOS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Bonhomme Delphine^ORCID,Santecchia Ignacio^ORCID,Vernel-Pauillac Frédérique^ORCID,Caroff Martine^ORCID,Germon Pierre^ORCID,Murray Gerald^ORCID,Adler Ben,Boneca Ivo G.^ORCID,Werts Catherine^ORCID

Funder

investissement d'avenir ANR

programme Bettencourt

Institut Carnot Pasteur Microbes et Sante

Fondation pour la Recherche Medicale

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference83 articles.

1. Global morbidity and mortality of Leptospirosis: a systematic review;F Costa;PLoS Negl Trop Dis,2015

2. Leptospirosis renal disease: emerging culprit of chronic kidney disease unknown etiology;C-W Yang;Nephron,2018

3. De la Peña Moctezuma A. Leptospira and leptospirosis;B Adler;Vet Microbiol,2010

4. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen;AI Ko;Nat Rev Microbiol,2009

5. Live imaging of bioluminescent Leptospira interrogans in mice reveals renal colonization as a stealth escape from the blood defenses and antibiotics;G Ratet;PLoS Negl Trop Dis,2014

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis;eLife;2024-05-31

2. Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis;eLife;2024-05-31

3. Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis;2024-05-20

4. S100A9 interacts with a dynamic region on CD14 to activate Toll-like receptor 4;2024-05-15

5. Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis;2024-03-05